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Abstract
Background: The implantation of stentless valves is technically demanding and the outcome may depend on the
performance of surgeons. We studied systematically the role of surgeons and other possible determinants for mid-term
survival, postoperative gradients and Quality of Life (QoL) after aortic valve replacement (AVR) with Freestyle® stentless
bioprostheses.
Methods: Between 1996 and 2003, 587 patients (mean 75 years) underwent AVR with stentless Medtronic Freestyle®
bioprostheses. Follow-up was 99% complete. Determinants of morbidity, mortality, survival time and QoL were
evaluated by multiple, time-related, regression analysis. Risk models were built for all sections of the Nottingham Health
Profile (NHP): energy, pain, emotional reaction, sleep, social isolation and physical mobility
Results:  Actuarial freedom from aortic valve re-operation, structural valve deterioration, non-structural valve
dysfunction, prosthetic valve endocarditis and thromboembolic events at 6 years were 95.9 ± 2.1%, 100%, 98.7 ± 0.5%,
97.0 ± 1.5%, 79.6 ± 4.3%, respectively. The actuarial freedom from bleeding events at 6 years was 93.1 ± 1.9%. Estimated
survival at 6 years was similar to the age-matched German population (61.4 ± 3.8 %). Predictors of survival time were:
diabetes mellitus, atrial fibrillation, peripheral vascular disease, renal dysfunction, female gender > 80 years and patients
< 165 cm with BMI < 24. Predictive models showed characteristic profiles and good discriminative powers (c-indexes >
0.7) for each of the 6 QoL sections. Early transvalvular gradients were identified as independent risk factors for impaired
physical mobility (c-index 0.77, p < 0.002). A saturated propensity score identified besides patient related factors (e.g.
preoperative gradients, ejection fraction, haematological factors) indexed geometric orifice area, subcoronary
implantation technique and individual surgeons as predictors of high gradients.
Conclusion: In addition to the valve size (in relation to body size), subcoronary technique (versus total root) and various
patient-related factors the risk of elevated gradients after stentless valve implantation depends, considerably on the
individual surgeon.
Although there was no effect on survival time and most aspects of QoL, higher postoperative transvalvular gradients 
affect physical mobility after AVR.
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Background
Stented bioprostheses are considered at risk of structural
failure and a non physiological flow pattern. Since the
rigid stent is considered to be incremented in these disad-
vantages, stentless bioprostheses were developed. During
the last years stentless bioprostheses have been used fre-
quently and clinical outcome has been demonstrated [1-
3].
The implantation of stentless valves is considered as tech-
nically more demanding. Nevertheless no increase in peri-
operative risk in comparison to the implantation of
stented bioprostheses or mechanical valves was observed
in our own [4] and the experience of others [5-8] and
favourable hemodynamic performance of the stentless
valves has been demonstrated [1,2,9-11]. However, differ-
ent groups have observed a heterogeneity in transvalvular
Doppler gradients early after implantation and some
patients have been found to have higher transvalvular gra-
dients than anticipated [1,12]. It is still unclear to what
extent patient related factors (e.g. preoperative gradient),
characteristics of the early postoperative period like ele-
vated stroke volume, local oedema and hematoma or
other surgical factors are associated with this phenomena.
[13]; however it was assumed that elevated postoperative
gradients observed in stentless valves depend to a larger
extent on the surgeon's skill and experience [1,12]. It is
also a matter of debate if higher gradients early after sur-
gery are just a transient phenomena or are persistent over
time, affecting clinical outcome [1,12-14].
The purpose of the present study is to estimate the clinical
importance of the individual surgeons for quality of life
(QoL) and survival after aortic valve replacement (AVR)
with Freestyle® stentless bioprostheses. Thereby early post-
operative gradients, the relationship between prosthesis-
size and patient size, the implantation technique (subcor-
onary versus total root) and a wide spectrum of patient's
characteristics including online accessible laboratory val-
ues were used as risk-adjustment variables in multivariate
analysis.
Methods
Patient Population
Between April 1996 and December 2003, 587 patients
older than 60 years underwent AVR with the stentless bio-
logical Medtronic Freestyle® Prosthesis (for age distribu-
tion see additional file 1). This group of patients
represents 31 % of all patients receiving aortic valve pros-
thesis in this age group in our centre. The choice of the
prosthesis type was according to surgeon's preference and
patient's choice after informed consent. Additional files
2&3 show the operative and preoperative characteristics
of the patient population. All patients have signed an
informed consent for the operation, for quality control
measures and the follow-up studies.
The indexed geometric orifice area (IGOA) were calcu-
lated by the internal diameters for corresponding valve
sizes reported by the company [Data from Medtronic:
Valve size 19, 21, 23, 25, 27 – Internal Diameters 16, 18,
20, 21.5, 23.5] divided by BSA.
Technique of implantation and the individual surgeons
All operations were performed using standard cardio-pul-
monary bypass techniques with systemic normothermia
and both antegrade and retrograde hyperkalemic cold
blood cardioplegia. The subcoronary implantation was
performed using a 4/0 Prolene continuous running suture
for both, the first and second suture line. The prosthesis
usually was 120° rotated in order to place the Dacron cov-
ered muscular part of the implant towards the human
non-coronary sinus. Total root implantation was per-
formed using a 4/0 Prolene continuous running suture for
the annular implantation and distal anastomoses to the
aorta and a 5/0 Prolene suture for coronary ostia re-
implantation. The individual surgeons were included into
the multivariate models as nominal data. The majority of
the stentless valves were implanted by 5 surgeons (sur-
geons A-E), one surgeon has implanted only 28 valves
(surgeon F); a group of younger surgeons, who operated a
total of 15 valves, were subsumed as a mixed group M.
Echocardiography
Intraoperative transesophageal echocardiography and
transthoracic echocardiographic control before hospital
discharge (4 to 7 days after AVR) under rest were per-
formed by experienced cardiologists. Gradients from the
pre-discharge echocardiography were used as variable for
the present study. Mean transvalvular gradient was calcu-
lated by continuous wave Doppler using the modified
Bernoulli equation. In cases with unusual higher gradients
or other irregular findings a second opinion by a colleague
was asked for.
Follow-up
Follow-up information was obtained 6 month after sur-
gery, in 2000, 2001 and 2003 by mailed questionnaires
and completed by telephone interviews. Follow-up was
99% complete. Mean follow-up time was 32 ± 23 months.
The follow-up questionnaire consisted of a quality of life
(QoL) assessing questionnaire, the Nottingham Health
Profile (NHP) [15], and general questions concerning
postoperative complications, further hospitalisation and
NYHA status.
Statistical Analysis
Statistical analysis was performed using the software pack-
age SPSS (SPSS Inc, Chicago, IL).Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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For each patient included in the present study, 49 pre-
operative characteristics were retrieved from the clinical
information system and the consolidated database of our
Data Mart system [16]. The data is based on continuous,
online input from the anaesthesiological, cardio-surgical
quality assurance and the laboratory data of the clinical
chemistry [Tables a1, a2, additional files].
Valve-related morbidity was estimated by life-table analysis
By logistic regression the following categorical outcome
variables were analysed: 30-days- and 6-months-mortality
and QoL. NHP-scores above the values of the general Ger-
man population of men and women of the same age [17]
were defined as an impaired QoL and were coded by 1. We
did not analyze the QoL as continuous data, because the
NHP-scores were not normally distributed. In order to
assess the effect of missing data in the models for Quality
of Life, we have recalculated all models. Firstly, we input-
ted all missing data as "impaired" (worst case); secondly,
we inputted all missing data as "non impaired" (best
case).
Predictors for survival time were identified by Cox-regression analysis
For variable selection of all multivariate regression mod-
els, the Akaike Information Criterion (AIC = Deviance of
the model + 2 * number of included parameters) was cal-
culated for variables showing a difference for the outcome
variable with a p value smaller than or equal to 0.25. The
variables were included into multiple regression models
in a stepwise way. The AIC was calculated each time a var-
iable was included. The final model was reached when no
more reduction in AIC was observed. To establish linear
dependency of outcome from continuous variables,
patient population was divided into subgroups of the
same size. The logit of the outcome variable was calcu-
lated within each group. In the case of a nonlinear
increase or decrease of an event, the AIC of the models was
determined for several cut points or quadratic relations.
For Cox-analysis the different Kaplan-Meier curves were
inspected after dividing the patient population in equally
sized subgroups. The relevant cut points were then deter-
mined by minimization of the AIC of the Cox-model.
Results
The postoperative mortality after 1 and 6 months was
3.1% (18 patients) and 7.3 % (43 patients) respectively.
During follow-up time up to 86 months, 97 patients of
the hospital survivors (569 patients) died. The actuarial
survival rate at 6 years was 61.4 ± 3.8 % and comparable
to the estimated survival function for 75 year-old male
and female Germans (Fig. 1).
76% of all survivors (356 patients) responded to the
mailed questionnaire, assessing NYHA-status and QoL
and those who did not respond were contacted by tele-
phone. Of all non-responders (N = 113) the reasons for
non-responding were non-cardiac-illness (8%), cardiac
illness (19%), disagreement (34%), staying abroad (2%)
and without reason (willingly answered on the phone,
however, did not return the questionnaire) (38%).
The QoL after AVR with the stentless bioprosthesis over
the follow-up time was compared to the general German
population of the same age and gender [17] (figure 2).
Apart from pain, which showed significantly lower values,
all sections had normal values after AVR.
Valve-related morbidity
Actuarial freedom from aortic valve re-operation, struc-
tural valve deterioration, non-structural valve dysfunc-
tion, prosthetic valve endocarditis and thrombembolic
events at 6 years were 95.9 ± 2.1%, 100%, 98.7 ± 0.5%,
97.0 ± 1.5%, 79.6 ± 4.3%, respectively. In 1389 patient-
years, twelve patients had to be re-operated (0.9%/pt-yr).
The indications to re-operation were mainly due to out-
flow obstruction. No significant aortic insufficiency was
observed (additional file 4). The quality of life after re-
replacement of aortic valve was impaired for the sections
energy, pain, sleep and physical mobility.
80 (16.8%) patients required anticoagulation therapy due
to co-morbidities and 15 major bleeding events were
observed (1.1%/pt-yr). The actuarial freedom from bleed-
ing events at 6 years was 93.1 ± 1.9%.
Survivor functions for patients after AVR compared to the  age- and gender matched German population Figure 1
Survivor functions for patients after AVR compared 
to the age- and gender matched German population. 
The actuarial survival rate at 6 years was 61.4 ± 3.8 % and 
comparable to the estimated survival function for 75 year-old 
male and female Germans.Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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Predictors of valve size
Male patients usually received larger stentless prostheses
than female patients: valve size 23 and 25 was implanted
in 73% of the male patients and valve size 21 and 23 in
86% of the female patients.
The linear regression model revealed subcoronary
implantation technique (p < 0.001), female gender (p <
0.001, body height (p < 0.001), age (p = 0.02), BMI (p =
0.046), re-replacement of the aortic valve (p = 0.01) as
predictors for valve size.
Determinants of mortality and survival time
Predictors of 30-day, 6-month mortality and survival time
are presented in table 1. In a first step we examined
whether valve size was an independent risk factor for out-
come. To adjust for patient-related factors correlated with
valve-size, we analysed the interactions of the predictors
of valve size (see above) together with Body Surface Area
(BSA) for all models. Continuous variables were checked
for possible cut points: In the model of 30-day-mortality
we studied the linearity of age for female and male
patients separately. As a possible cut point for female
patients may be over 70 years interaction terms such as
female by age over 70, 71 etc. were successively included
into the model. In the model of 6-months mortality BSA
was checked for linearity. Since a possible cut point for
BSA may be between 1.75 and 1.8 m2, BSA smaller than
1.75, 1.76, etc. were successively included into the model.
In the Cox-model the survival curves were inspected for
possible cut points at age of 79 or 80 years, body height at
nearly 165 cm, BMI at 24 and for BSA at nearly 1.79. All
interactions between these variables and variables of the
linear regression models were analysed.
Table 1: Predictors of 30-day- and 6-months-mortality and survival time. Apparently valve size is a risk factor in the first step of the 
analysis. However, after adjustment for gender, age, BSA, BMI and body size, valve size disappeared (p < 0.05)
Models for
Preoperative risk factors 30-day mortality 6-months mortality Survival time
OR 95% CI OR 95% CI HR 95% CI
Myocardial decompensation 2.9 1.1–7.2
Diabetes mellitus 2.7 1.3–5.5 2.0 1.3–3.0
Atrial fibrillation 2.3 1.1–5.2 2.8 1.8–4.4
Peripheral vascular disease 2.2 1.2–4.0
Antithrombine III (%) 0.97 0.94–0.99 0.96 0.94–0.99
Urea concentration (mg/dl) 1.02 1.01–1.03 1.02 1.011.02
Valve size p = 0.009 p = 0.05 p = 0.02
After Variable transformation:
Female and age > 74 years 4.0 1.4–11.0
BSA < 1.78 m2 3.0 1.51–6.07
Female and age > 80 years 1.8 1.03–2.94
BMI < 24 and body size < 165 cm 1.7 1.02–2.93
Valve size p = 0.13 p = 0.47 p = 0.22
CI = Confidential Interval
HR = Hazard Ratio
OR = Odds Ratio
p = p-value of model improvement
Mean scores of the six NHP sections compared to the age-  and gender-matched general German population Figure 2
Mean scores of the six NHP sections compared to 
the age- and gender-matched general German popu-
lation. The QoL after AVR with the stentless bioprosthesis 
over the follow-up time was compared to the general Ger-
man population of the same age and gender. Besides from 
the section "pain" the patients after AVR showed no signifi-
cant differences to the normal population. Our observation 
that the patients after AVR have lower values for pain may be 
explained by misunderstanding of the questionnaires: the 
patients thought that the question asking for pain mean only 
cardiac related pain, whereas in the general population all 
other kinds of pain were included.Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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After adjusting for these factors, valve size was no longer a
risk factor in all 3 models (table 1), nor was indexed geo-
metric orifice area.
Determinants of QoL
The percentage of patients after AVR with NHP-scores
higher than the age and gender matched general German
population was 43% in the section energy, 25% in the sec-
tion pain, 29% in the section emotional reaction, 27% for
sleep, 18% for social isolation and 41% for physical
mobility.
Preoperative risk factors for impaired QoL are shown in
Table 2 (+coumarin). The model for impaired physical
mobility had good discriminative powers (c-index =
0,78). C-indexes for energy, pain, emotional reaction,
sleep, social isolation were 0,72, 0,37, 071, 071 and 0,74.
Including the size of implanted valves and the indexed
geometric orifice area did not improve the models signif-
icantly (p < 0.1).
In order to assess the effect of missing data in the models
for Quality of Life, we have recalculated all models for the
worst and best case scenarios, where all missing data were
imputed as "impaired QoL" respectively "non impaired
QoL". In both, the worst- and best case scenarios, the
identified risk factors for Quality of Life did not change
and the c-indexes for all models decreased, suggesting that
firstly, the models have enough stability and secondly,
that the non responding patients, have a mixed risk pro-
file, not exclusively belonging to the high risk or low risk
group.
16% of the patients (N = 58) took coumarin during fol-
low-up, mainly due to atrial fibrillation.
Impact of early postoperative gradient on mortality and 
QoL
The mean and maximum transvalvular pressure gradients
at hospital discharge for each valve size and different
implantation technique are shown in table 3. Postopera-
tive mean and maximum transvalvular pressure gradients
did not influence 6-months mortality and survival times
(table 1, p = 0.87, p = 0.82; respectively; p = 0.78, p = 0.9).
The postoperative mean and maximum transvalvular
pressure gradients had no impact on the QoL sections
energy (p = 0.54, p = 0.33), pain (p = 0.34, p = 0.19), emo-
tional reaction (p = 0.33, p = 0.08), sleep (p = 0.9, p =
0.89) and social isolation (p = 0.71, p = 0.81, respectively
for mean and maximum pressure gradients). However,
increasing postoperative mean transvalvular pressure gra-
dients were identified as independent risk factors for
impaired physical mobility (p = 0.002, Table 2).
In a logistic regression model for non-responding the
postoperative mean and maximum transvalvular pressure
gradients were no risk factors (p-values for model
improvement: 0.69 and 0.42, respectively).
Table 2: Significant predictors of impaired QoL are listed
Risk factors Energy 
[OR;95%CI]
Pain 
[OR;95%CI]
Emotional reaction 
[OR;95%CI]
Sleep 
[OR;95%CI]
Social isolation 
[OR;95%CI]
Physical mobility 
[OR;95%CI]
Age 1.1; 1.0–1.1 (> 76), 2.8; 1.7–4.9 (> 79), 2.6; 1.4–4.8 1.1; 05–1.2 (> 70), 5.6; 1.9–16.7), 1.1; 1.08–1.2
Female gender 2.2; 1.4–3.6 2.3; 1.4–3.9 2.9; 1.6–5.7 2.7; 1.6–4.3
Lower potassium 1 0.4; 0.2–0.7
Higher creatinine 2 2.7; 1.3–5.7
BMI 3 1.1; 1.0–1.2 1.0; 1.0–1.1
History of syncope 2.1; 1.0–4.1
Advanced NYHAclass 2.3; 1.4–4.0 2.0; 1.2–3.3 1.7; 1.1–2.8
Lower hemoglobine (< 13) 2.0; 1.2–3.5
History of MI 4 3.2; 1.3–7.5
COPD 5 2.6; 1.3–5.3
Previous CABG 6.2; 4.5–7.9
De Ritis-ratio (AST/ALT) 6 1.6; 1.1–2.4
Neurological disorders 2.2; 1.0–4.8 3.7; 1.5–8.7
Concomitant CABG 1.7; 1.01–2.8
Higher urea7 1.01; 1.0–1.04
Non-elective procedure 2.5; 1.4–4.7
Pacemaker before AVR 10.5; 1.1–99.6
Mean gradients (1 mmHg) 1.1; 1.0–1.1
Abbrevations: 1: potassium concentration (mmol/l); lower potassium probably as marker for diuretic therapy, 2: creatinine concentration (mg/dl), 3: 
body mass index, 4: Myocardial infarction, 5: Chronic obstructive pulmonary disease, 6 De ritis ratio: De ritis-ratio as marker for liver damage, e.g. 
ethanol intake 7 Urea concentration (mg/dl),Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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Risk factors for higher transprosthetic gradients and 
influence of the surgeons
As impaired physical mobility due to high transvalvular
pressure gradients may reflect the impact of valve design
on outcome and may in the consequence also affect mid-
term survival, we were interested in the factors determin-
ing high early postoperative transvalvular gradients. As a
dichotomic variable "mean gradient higher than 20 mm
Hg yes or no" became significant (p = 0.008) in the model
of impaired physical mobility, a saturated propensity
score predicting mean transvalvular gradients higher than
20 mm Hg (table 4) was calculated. This score well
describes patients with gradients higher than 20 (28% of
all patients) as the c-index was 0.79 and the p-value of the
variable "mean gradient higher than 20 mm Hg yes or no"
became not significant (p = 0.057) after including the pro-
pensity score into the model of impaired physical mobil-
ity. Figure 3 shows the impact of several predicting factors
on the risk of having a postoperative transvalvular pres-
sure gradient higher than 20 mm Hg. The main factors
predicting high postoperative pressure gradients are
indexed geometric orifice area, subcoronary implantation
technique, preoperative transvalvular gradients and the
individual surgeon. Three surgeons (surgeons C-E) had
significantly higher gradients than surgeons A, B, F and
the mixed group M. Common parameters assessing "sur-
gical experience" like years in cardiac surgery, number of
valve cases performed or number of valves implanted did
here not explain the differences between the surgeons
concerning transvalvular gradients (table 5). These differ-
ences were observed in subcoronary technique for each
valve size from 21 to 25 (table 6).
We observed learning curves in surgeons A, C, D, E,
whereas gradients through stentless valves implanted by
surgeons B, F and the mixed group M were low already in
the beginning of their experience. An example of a learn-
ing curve for one surgeon is provided in figure 4.
Discussion
Encouraged by previous reports about the excellent hemo-
dynamic performance and the good initial experience,
stentless valves are frequently implanted by all surgeons
in our institution.
Table 4: Saturated propensity score predicting a mean transvalvular gradient after AVR > 20 mmHg
Predictors Odds ratio 95% CI
Male gender 1.83 1–3.36
Body height (cm) 0.98 0.93–0.99
Subcoronary implantation technique 11.4 2.59–49.9
Indexed geometric orifice area 0.12 0.05–0.28
Less-experienced surgeon 3.64 2.34–5–66
Ejection fraction (%?) 1.01 1–1.03
Preoperative maximum transvalvular gradient (mmHg) 1.01 0.99–1.02
White blood cell count (cells*1000/µl) 1.11 1.02–1.22
Total serum protein (g/dl) 0.55 0.4–0.77
Glutamic-oxalacetic transaminase (U/l) 0.97 0.93–0.99
Potassium (mmol/l) 0.48 0.29–0.78
Mean corpuscular volume (fl) 1.04 0.99–1.08
Atrial fibrillation 0.6 0.3–1.2
Chronic pulmonary disease 1.5 0.81–2.75
Renal insufficiency 1.41 0.82–2.41
Peripheral occlusive arterial disease 0.56 0.2–1.56
CI – confidential interval
Table 3: Mean and maximum transvalvular pressure gradients (mmHg) at discharge (5 to 7 days after AVR)
Subcoronary implantation Total root replacement
Valve size Mean N Max N Mean N Max N
19 29.8 ± 14.4 9 54.2 ± 23.2 9 - 0 - 0
21 22.0 ± 8.9 127 40.4 ± 14.5 119 13.7 ± 4.2 3 25.7 ± 7.5 3
23 19.6 ± 7.6 176 35.5 ± 12.8 149 13.5 ± 6.0 27 25.3 ± 10.1 26
25 17.0 ± 6.9 100 31.0 ± 14.9 80 10.8 ± 5.0 20 19.8 ± 10.9 19
27 14.8 ± 5.7 50 26.7 ± 9.4 47 7.2 ± 2.0 9 13.2 ± 4.3 9Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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The 30 day mortality in our study equals to the reports of
a multicenter evaluation of the Freestyle valve (3.1% ver-
sus 3.0%) [18] and the survival rate, after 5 years was sim-
ilar to a series with a comparable mean age of 75 years
[19] (73%, versus 72% in our study). In accordance with
other studies we observed virtually no structural valve
deterioration or important aortic insufficiency with the
Freestyle stentless valves [3].
Nevertheless, we observed in a considerable percentage of
patients higher transvalvular gradients. They were in aver-
age higher than reported previously [1,1,3,11,20,21],
what may be partly explained by the more frequent use of
subcoronary technique in patients with small aortic
roots., but also previous studies reported a heterogeneity
of the transvalvular gradients and suboptimal hemody-
namics with the freestyle stentless valve early postopera-
tive [1,12,13,22]. Up to now, both the risk factors for
higher gradients and their clinical relevance are still
poorly defined. It was argued that echocardiography tends
to overestimate the transvalvular gradient in stentless
valves, because the velocity profile of stentless valves is
more parabolic in the early postoperative period, [1] and
furthermore that elevated gradients will decline by resolu-
tion of paravalvular haematoma and the normalization of
postoperative hemodynamics. [1,3,12]. On the other
hand, previous studies showed that transvalvular gradi-
ents remained high at follow-up and left ventricular mass
regression was subsequently less [12,22]. Up till now, a
possible association of postoperative gradients with clini-
cal symptoms was not studied in stentless valves. Even, in
other valve types, the clinical significance of residual left
ventricular outflow tract obstruction after AVR is still
under debate [23].
We could not detect an impact of neither the early postop-
erative transvalvular gradient nor the IGOA on morbidity
or mid-term mortality, but physical mobility at follow-up
was impaired with increasing mean transvalvular gradient
especially with mean gradients > 20 mmHg. Also our find-
ing that apart from physical mobility, none of the other
NHP sections: energy, pain, emotional reaction, sleep, or
social isolation were affected, indicates an exercise
dependent mechanism similar to what occurs in patients
with hemodynamically important stenosis. Previous stud-
ies have suggested that the residual transprosthetic pres-
sure gradient results in an increased LV workload, thus
hampering the regression of LV mass after AVR and subse-
quently functional recovery after AVR [24,26]. In addition
it was demonstrated that, in patients with AS and angio-
graphically normal coronary arteries, the improvement of
coronary flow reserve after AVR is directly dependent on
the improvement of valve EOA that is achieved with AVR
[27]. Hence, the increased LV systolic pressure associated
Table 6: Mean transvalvular gradients for the main valve sizes by surgeon
Valve Size
21 mm 23 mm 25 mm
Surgeons N cases Mean ± StDev [mmHg] Range [mmhg] Mean ± StDev [mmHg] Range [mmHg] Mean ± StDev [mmHg] Range [mmHg]
Trainees 43 19 ± 2.4 0 16 ± 1.8 .- 17 ± 2.3 .-
A 53 24 ± 2.3 20 22 ± 1.7 24 16 ± 2.3 22
B 74 25 ± 1.9 27 21 ± 1.3 35 19 ± 1.8 28
C 280 21 ± 1.1 40 18 ± 0.8 27 16 ± 0.9 28,4
D 41 23 ± 2.7 38 26 ± 1.7 35 19 ± 2.8 35
E 67 20 ± 1.9 25 17 ± 1.4 30 13 ± 1.7 16
F 28 10 ± 8.2 27 12 ± 2.0 19 12 ± 2.6 18
ANOVA P = 0.1 p < 0.001 P = 0.1
Table 5: Experience of the surgeons at end of 2004
Surgeons Years in 
Cardiac Surgery
Major cardiac surgery 
performed [N]
Valve implantation 
performed [N]
Freestyle valve implantation 
performed [N]
Mean transprosthetic gradients
in subcoronary technique
(ANOVA, p < 0.001)
F > 20 > 5000 > 1000 26 14
E > 10 2500 400 66 17
C > 20 > 4000 > 1000 280 18
A > 10 2000 400 53 22
B > 15 2500 500 74 22
D > 10 1000 250 41 24Journal of Cardiothoracic Surgery 2007, 2:40 http://www.cardiothoracicsurgery.org/content/2/1/40
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with residual transvalvular gradients may compromise the
normalization of coronary flow reserve after AVR. Both
mechanisms predispose to decreased exercise tolerance
and explain our finding of an impaired physical mobility
in patients with higher gradients after AVR.
In a recent study no risk-adjusted impact of mean trans-
valvular gradients or IGOA on functional health-related
QoL was detected after AVR with mainly stented valves
[28]. The Duke Activity Status Index (DASI), used in this
study to measure activities of daily living such as house-
hold tasks, ambulation or personal care, shows similari-
ties to the section physical mobility of the NHP.
Nevertheless, this study was different from ours regarding
the study design. It may be possible that, due to the fact
that the mean follow-up time in our study was more than
3 times longer than in the above mentioned study, we
were able to prove an impact of the postoperative gradient
on QoL.
According to our data in stentless valves higher gradients
depend beyond the physical valve sizes and its relation to
body size, mainly on the interaction of subcoronary tech-
nique, the preoperative gradients with the individual sur-
geons.
By solving the multivariate equations in figure 2 we had
illuminated how with total root technique virtually no
increase of the risk for higher gradients with decreasing
IGOA was observed, whereas with subcoronary technique
the risk increase exponentially. Thus previous reports
could be redefined, where a threshold of a valve size equal
or smaller than 23 was mentioned as risk factor for higher
gradients [1,12]. In contrary to a study about the outcome
after human tissue valves for aortic valve replacement, a
limited performance of the individual surgeon in subcor-
onary technique did not result in more initial aortic regur-
gitation and early reoperation our series. [29]
It was already assumed that the performance of stentless
valves depends to a larger extent on the surgical experi-
ence [1,12]. Up to now only data were available concern-
ing 30 day mortality, where a significant decrease with
operator experience for both subcoronary and total root
technique was described [18]. In our study no significant
effect of individual surgeons on mortality was detectable,
but we were able to show to which degree the hemody-
namic performance of stentless valves depends on the
individual surgeon and proved its clinical consequences.
In contrary to the study about learning curve of tissue
valve implantation, where an experience of more than 38
cases was associated with better performance, we could
Learning curve of one surgeon concerning transprosthetic  gradients after stentless valve implantation [p < 0.001] Figure 4
Learning curve of one surgeon concerning transpros-
thetic gradients after stentless valve implantation [p 
< 0.001]. The example of one surgeon shows that the mean 
gradients in subcoronary technique decrease during a time 
period of 8 years. Beside proper valve sizing and use of total 
root technique in difficult cases with small aortic roots, the 
phenomena can be best explained by the increasing ability of 
the surgeon to fit the valve smoothly into the aortic root and 
to handle the various aortic root geometries.
Risk factors for higher transvalvular gradients after stentless  valve implantation Figure 3
Risk factors for higher transvalvular gradients after 
stentless valve implantation. By solving the multivariate 
equations we had illuminated the importance of the domi-
nant risk factors for higher gradients after stentless valve 
implantation: valve size in relation to BSA (IGOE), subcoro-
nary technique, preoperative gradients, and the surgeons C, 
D, E. Other risk factors (cardiac, haematological) were less 
important (se table 4). With total root technique virtually no 
increase of the risk for higher gradients with decreasing 
IGOA was observed, whereas with subcoronary technique 
the risk increases exponentially.
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not define the number of cases needed, until the con-
stantly better gradients where achieved, due to large vari-
ations between the surgeons; their skills and differences in
their individual histories of training seems to be more
important than experience over time and the number of
cases.
According to our and others experiences [1,12] higher
transvalvular gradients through stentless valves may
develop by already slight distortions of the valve, horizon-
tal or vertical folding of valve tissue into the outflow tract,
oversizing, impaired movements of the non-coronary
cusp or due to paravalvular hematoma. Especially in
patients with a discrepancy between annulus and sinotu-
bular junction dimensions, calcification in the aortic
sinuses, unusual angles between the coronary ostia, bicus-
pid valves or small aortic roots, the difficulty of stentless
valves implantation increases whereas the reproducibility
decreases.
Limitation
In our study we considered both transvalvular gradients
and IGOA as possible determinant of outcome, but the
Effective Orifice Area (EOAs) was not assessed. Neverthe-
less a correlation of the mean transvalvular gradients with
the EOA, the impedance to the left ventricular outflow
and left ventricular mass regression is well established for
native valves, conventional prosthesis [30] and stentless
xenografts, in rest and in exercise [1,3,8,12,13,31].
Despite its known limitations, an accurate measurement
of the pressure gradient is still sufficient to make clinical
decision [30]. In order to adjust for remaining discrepan-
cies between transvalvular gradient and EOAs, we
adjusted for ejection fraction and other variables known
to influence the gradients like blood composition, ejec-
tion fraction, atrial fibrillation and preoperative gradients.
Conclusion
The implantation of Freestyle stentless valves in subcoro-
nary technique is technically demanding and therefore
affords an extraordinary expertise, especially in managing
small valve sizes (in relation to BSA), cases with a difficult
aortic root geometry, sinus calcifications and severe left
ventricular hypertrophy. Transvalvular gradients rise eas-
ily when the valve does not smoothly fit within the aortic
root (whereas aortic insufficiency is extremely uncom-
mon). Despite the well-known limitations of the transval-
vular gradient for measuring performance of aortic valves,
in the majority of patients it reflected sufficiently the tech-
nical quality of implantation and correlated significantly
with physical mobility years after the operation. In order
to avoid unfavourable performance curves ("learning
curves") in technically demanding procedures like stent-
less valve implantation it is recommendable to apply
more profoundly the recognized methods of surgical
teaching (e.g. prolonged expert guidance, cognitive task
analysis, model training [32]) and thereby optimizing the
diffusion of such a new technology [33].
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